IVD

We are an EN ISO 13485 certified EU-located company developing and producing CE IVD kits based on real-time PCR and NGS detection methods.

Our IVD kits fall into five categories: clinical genetics, hematology, pharmacogenetics, oncology and microbiology.

Our typical partners are end-users of the kits (mostly in CZ and SK), business partners and distributors mostly within the EU. We are looking for business partners and/or distributors worldwide who can fit the portfolio of our products, either the whole or a part of it, to their sales strategy (see here).

gb PHARM UGT1A1 gb PHARM UGT1A1

gb PHARM UGT1A1 gb PHARM UGT1A1

The real-time PCR diagnostic kit allows detection of variants of 5TA (UGT1A1 * 36), 7TA (UGT1A1 * 28), 8TA (UGT1A1 * 37), and 211G / A SNP UGT1A1 polymorphisms. The detection is based on the Q-FRET probe and uses the analysis of melting curves for multiplex genotyping.

More
gb PHARM DPYD*2A gb PHARM DPYD*2A

gb PHARM DPYD*2A gb PHARM DPYD*2A

The kit is intended for detection of mutation DPYD*2A (IVS14+1G>A) in gene for dihydropyrimidine dehydrogenase in human genomic DNA by real-time PCR method (allelic discrimination).

More
New
gb PHARM CYP2C19 gb PHARM CYP2C19

gb PHARM CYP2C19 gb PHARM CYP2C19

Kit for detection of CYP2C19*2, CYP2C19*3 and CYP2C19*17 gene mutation. The detection principle is based on a real-time polymerase chain reaction (qPCR) using fluorescent labeled probes (allelic discrimination).

More
gb PHARM Warfarin gb PHARM Warfarin

gb PHARM Warfarin gb PHARM Warfarin

The kit is intended for detection of mutation CYP2C9*2, CYP2C9*3 and VKORC1 G1639A in human genomic DNA by real-time PCR method (allelic discrimination).

More
gb PHARM TPMT gb PHARM TPMT

gb PHARM TPMT gb PHARM TPMT

The kit is intended for detection of TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C in TPMT gene in human genomic DNA by realtime PCR method (allelic discrimination). The kit allows the determination of haplotypes TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C in homozygous or heterozygous form. The kit does not distinguish genotype *1/*3A (two mutations in cis form) from 3B*/*3C (the incidence of the composite heterozygote *3B/3C* is unlikely in Caucasians).

More
gb GENETIC Gilbert gb GENETIC Gilbert

gb GENETIC Gilbert gb GENETIC Gilbert

The kit is intended for detection polymorphism TA (allele 7TA) in gene UGT1A1 in human genomic DNA. Detection is based on polymerase chain reaction (PCR) with analysis of melting curves using fluorescently labelled probe.

More
gb GENETIC A1AT gb GENETIC A1AT

gb GENETIC A1AT gb GENETIC A1AT

The kit is intended for detection of mutations PI*S and PI*Z in the alpha 1 antitrypsin gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb GENETIC FRUCTO gb GENETIC FRUCTO

gb GENETIC FRUCTO gb GENETIC FRUCTO

The kit is intended for detection of mutation A149P, A174D, N334K and deletion del4E4 in the ALDOB gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb GENETIC LACTO gb GENETIC LACTO

gb GENETIC LACTO gb GENETIC LACTO

The kit is intended for detection of mutations LCT (C13910T) and LCT (G22018A) in the lactase gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More